Brigit Biofarmaka Teknologi Tbk. vs Samudera Indonesia Tbk. — how do they compare? Brigit Biofarmaka Teknologi Tbk. trades at Rp240 (market cap 164.65B, 46K 24h volume), while Samudera Indonesia Tbk. trades at Rp304 (market cap 4.91T, 3.05M 24h volume). The key difference: Samudera Indonesia Tbk. is far larger — about 29.8× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Samudera Indonesia Tbk. is more actively traded (3.05M versus 46K). Which is the better fit depends on your goals.
| OBAT | SMDR | |
|---|---|---|
Market Cap | 164.65B | 4.91T |
Volume | 46K | 3.05M |
Lot | 460 | 30.52K |
Turnover | 11.1M | 917.81M |
Average Price | 241.33 | 300.69 |
Value | 11.1M | 917.81M |
Indicative Equilibrium Price | 238 | 300 |
Indicative Equilibrium Volume | 100 | 2.1K |
Trailing returns across standard periods
Latest headlines on both assets
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →PT Samudera Indonesia Tbk (the Company) was established on November 13, 1964 under the framework of the Domestic Capital Investment Law No. 6 of 1968 as amended by Law No. 12 of 1970, based on notarial deed No. 33 of Soeleman Ardjasasmita, S.H. PT. Samudera Indonesia Tbk offers a full range of transportation services from feeder, tanker, offshore and land transportation for containers and heavy equipment to container depots and warehousing as well as freight forwarding services. In 1997, SSL, a subsidiary, listed on the Singapore Exchange Securities Trading Ltd.
Read more on SMDR →